A randomized Phase IIa trial evaluating the safety and efficacy of a new centrally acting analgesic in subjects with pain due to diabetic polyneuropathy

To evaluate the analgesic efficacy of GRT6005 in subjects with moderate to severe pain due to diabetic polyneuropathy